Search
for
Sort by
Research 31–60 of 1000+
- Author response: Involvement of ILC1-like innate lymphocytes in human autoimmunity, lessons from alopecia areata
- Decision letter: Involvement of ILC1-like innate lymphocytes in human autoimmunity, lessons from alopecia areata
- 080 Mouse models of alopecia areata: C3H/HeJ mice versus the humanized AA mouse model
- 원형탈모증(alopecia areata)의 최신 이해와 치료
- Alopecia Areata
- Exogenous IL-27 prevents the development of alopecia areata
- Editors’ Picks
- DISRUPTION OF HAIR FOLLICLE IMMUNE PRIVILEGE IN ALOPECIA AREATA: ENIGMATIC MECHANISMS AND EMERGING CONCEPTS
- 331 Mitochondrial stress contributes to atopic dermatitis
- 328 The transcription factor CEBPB is a novel hub gene and multi-functional disease driver in Psoriatic skin inflammation
- ULBP3: a marker for alopecia areata incognita
- The immunopathogenesis of Alopecia Areata
- Updates In The Pathogenesis Of Alopecia Areata
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Janus Kinase Inhibitors against Other Biological Treatments in Alopecia Areata
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- Prior antigen experience influences the development of alopecia areata in C3H/HeJ mice 2258436
- CD4+ Treg expansion arrests disease progression in a pre-clinical model of alopecia areata
- Inhibiting Janus kinases to treat alopecia areata
- Mathematical model for alopecia areata
- Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity
- 431 Innate lymphoid cells type 1 may be new, non-antigen-specific player in the pathogenesis of alopecia areata
- Involvement of ILC1-like innate lymphocytes in human autoimmunity, lessons from alopecia areata
- 058 The pattern of Fas and Fas ligand expression in alopecia areata
- Butyrophilin-like 2 (BTNL2) to the Rescue: controlling autoaggressive dermal gamma delta (GD) T lymphocytes in human hair follicles (HFs) 3747
- Genome-wide association study in alopecia areata implicates both innate and adaptive immunity
- 2‐deoxy D‐glucose treatment does not elicit a hair growth response in alopecia areata
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of tofacitinib for treating alopecia areata
- 586 Increase in CD8+ effector memory cells re-expressing CD45RA (TEMRA) reflects disease activity and enables early prediction of therapeutic outcome in rapidly progressive alopecia areata